About Elegant Pharmaceuticals
Elegant Pharmaceuticals is a company based in Mumbai (India) founded in 1994. It operates as a B2B. Elegant Pharmaceuticals offers products and services including Amoxicillin Trihydrate, Ampicillin Trihydrate, and Atenolol. Elegant Pharmaceuticals operates in a competitive market with competitors including Viyash, Inventys, Blue Jet Healthcare, Ami organics and Aparna Pharmaceuticals, among others.
- Headquarter Mumbai, India
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website elegantpharma.com
- Legal Name Elegent Pharmaceuticals Limited
- Date of Incorporation 11 Jul, 1990
- Jurisdiction Mumbai, Maharashtra, India
- Net Loss-₹5,000
FY 2016 · 0% margin
- EBITDA-₹5,000
FY 2016 · 0% margin
Associated legal entities of Elegant Pharmaceuticals
Elegant Pharmaceuticals operates through Elegent Pharmaceuticals Limited, a listed company (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2016) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Elegent Pharmaceuticals Limited Listed CIN L24239MH1990PLC057214 | Active | 11 Jul 1990 | Mumbai, Maharashtra | – | – | 3 | View details |
Products & Services of Elegant Pharmaceuticals
Elegant Pharmaceuticals offers a comprehensive portfolio of products and services, including Amoxicillin Trihydrate, Ampicillin Trihydrate, and Atenolol.
Beta-lactam antibiotic for treating bacterial infections effectively.
Penicillin-class drug targeting bacterial infections in various applications.
Beta-blocker medication for managing hypertension and heart conditions.
Board of directors of Elegent Pharmaceuticals Limited (Elegant Pharmaceuticals)
Elegent Pharmaceuticals Limited is the primary company behind Elegant Pharmaceuticals. The board of Elegent Pharmaceuticals Limited currently have 3 directors; the longest-serving is Dhirendra Bhanulal Sanghavi, appointed in 1992. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Dhirendra Bhanulal Sanghavi DIN 03186560 | Managing Director | 23 Mar 1992 | 34 yrs 6 mo | Elegent Pharmaceuticals Limited |
| Manjula Bhanulal Sanghavi DIN 08287299 | Additional Director | 29 Nov 2018 | 7 yrs 10 mo | Elegent Pharmaceuticals Limited |
| Tejas Baijukumar Desai DIN 08287400 | Additional Director | 29 Nov 2018 | 7 yrs 10 mo | Elegent Pharmaceuticals Limited |
Financials of Elegant Pharmaceuticals
Figures of Elegent Pharmaceuticals Limited, the primary company behind Elegant Pharmaceuticals, for FY 2016. Net loss was -₹5,000 (0% margin). EBITDA was -₹5,000 (0% margin).
- -₹5,000Net loss · 0% margin
- -₹5,000EBITDA · 0% margin
- ₹4.39 CrPaid-up capital
Balance sheet, profit and loss, cash flow and ratios of Elegent Pharmaceuticals Limited are on its company page.
Detailed financial statements for Elegant Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Elegant Pharmaceuticals
Elegant Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Viyash, Inventys, Blue Jet Healthcare, Ami organics and Aparna Pharmaceuticals, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| viyash.com | 2019 | Hyderabad, India | $120.02M | 277 | APIs and intermediates are manufactured by Viyash as a CDMO. | |
| inventys.in | 2005 | Mumbai, India | $64.34M | 219 | Actives, advanced intermediates, and specialty chemicals are custom manufactured. | |
| bluejethealthcare.com | 1969 | Mumbai, India | – | 476 | CDMO focused on manufacturing, supplier, and development of intermediates & APIs | |
| amiorganics.com | 2007 | Surat, India | – | 4 | Advanced API intermediates are manufactured for pharmaceutical use. | |
| aparnapharma.com | 2008 | Hyderabad, India | $674,328 | 328 | API intermediates are manufactured by Aparna Pharmaceuticals as a CDMO. | |
| dudechem.com | 2019 | Berlin, Germany | $6.98M | – | CDMO focused on manufacturing of APIs and intermediates | |
| hindyslab.com | 2007 | Hyderabad, India | – | 285 | Manufactures and exports pharmaceutical intermediates for global markets. | |
| hsbiopharm.com | 2004 | Hangzhou, China | – | – | APIs, intermediates, and finished dosage forms are manufactured. | |
| enantilabs.com | 2007 | Hyderabad, India | – | 178 | Enanti Labs produces pharmaceutical intermediates and APIs in India with quality focus. |
Detailed competitors of Elegant Pharmaceuticals
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to Elegant Pharmaceuticals
10 companies that operate in the same segment as Elegant Pharmaceuticals (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Elegant Pharmaceuticals
Elegant Pharmaceuticals was founded in 1994.
Elegant Pharmaceuticals is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Elegant Pharmaceuticals Ltd., established in 1994, operates as a manufacturer and marketer of bulk drugs and APIs. It caters to various therapeutic segments, providing high-quality pharmaceutical solutions through innovative production processes. Based in Mumbai, India, the company focuses on global business practices, emphasizing quality, safety, and customer satisfaction in its operations. It supplies products to diverse categories while maintaining excellence in manufacturing and research.
Elegant Pharmaceuticals's top competitors include Inventys, Viyash and Blue Jet Healthcare.
Elegant Pharmaceuticals offers Amoxicillin Trihydrate, Ampicillin Trihydrate, and Atenolol.
Elegant Pharmaceuticals operates through Elegent Pharmaceuticals Limited.
The legal entities of Elegant Pharmaceuticals currently have 3 directors, including Dhirendra Bhanulal Sanghavi, Manjula Bhanulal Sanghavi, Tejas Baijukumar Desai.